Medline: After IPO In 2025, This Year Is A Bet On Continued Growth
ICUI or MDLN: Which Is the Better Value Stock Right Now?
Here is Why Medline (MDLN) is One of the Best Young Stocks with the Highest Upside Potential
Is Medline (MDLN) One of the Best Healthcare Stocks to Buy With the Highest Upside Potential?
Medline Inc. (MDLN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
FDA Warning Tests Medline Quality Systems And Earnings Story
Medline Inc. (MDLN) Presents at 46th Annual William Blair Growth Stock Conference Transcript
Baird Maintains Outperform on Medline, Lowers Price Target to $45
FDA Sends Warning Letter To Medline Over CGMP Violations For Finished Pharmaceuticals On May 28
Barclays Maintains Overweight on Medline, Lowers Price Target to $45
Medline's Prime Vendor model expands outside the United States
Medline Announces That Medline Canada Has Signed Its First Prime Vendor Agreement In The Country And Is The First Medline Prime Vendor Relationship Outside The United States
Medline Inc. announces closing of upsized secondary offering of Class A common stock
Medline announces participation in upcoming investor conferences
Medline Signs Prime Vendor Agreement With Rural Medical Services; Agreement Enables Access To Medline's Medical-Surgical Products And Supply Chain Solution Offerings
Assessing Medline (MDLN) Valuation After Recent Share Price Pullback
Medline Inc. announces pricing of upsized secondary offering of Class A common stock
Medline expands animal health portfolio with spay/neuter surgical packs
Medline Inc. announces launch of secondary offering of Class A common stock
Medline Announces Secondary Public Offering Of 60M Shares
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.